|
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$110
|
$297B |
4.6x |
10.0x |
|
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$26
|
$196B |
3.2x |
7.9x |
|
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€79
|
$128B |
2.4x |
8.0x |
|
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£19
|
$123B |
2.8x |
8.2x |
|
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 181
|
$69.8B |
4.2x |
12.5x |
|
UCB
|
Belgium |
Vaccines & Immunotherapies
|
€255
|
$58.4B |
6.7x |
21.7x |
|
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$44
|
$13.4B |
7.0x |
-4.2x |
|
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$114
|
$11.5B |
3.7x |
-9.3x |
|
Chongqing Zhifei
|
China |
Vaccines & Immunotherapies
|
CNY 17
|
$7.6B |
3.7x |
-39.8x |
|
Alk-Abello
|
Denmark |
Vaccines & Immunotherapies
|
DKK 208
|
$7.2B |
7.3x |
23.7x |
|
Wantai BioPharm
|
China |
Vaccines & Immunotherapies,
Pharma Diagnostics & Analytics
|
CNY 42
|
$7.1B |
24.1x |
568.4x |
|
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$6.4B |
58.0x |
N/A |
|
Vaxcyte
|
United States of America |
Vaccines & Immunotherapies
|
$54
|
$5.4B |
N/A |
-6.4x |
|
GSK India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Health & Beauty
|
INR 2408
|
$4.2B |
10.1x |
30.7x |
|
Hualan Biological Engineering
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 16
|
$3.6B |
5.3x |
14.3x |
|
Sinocelltech Group
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 42
|
$3.1B |
N/A |
N/A |
|
Walvax Biotechnology
|
China |
Vaccines & Immunotherapies
|
CNY 13
|
$2.7B |
7.5x |
26.1x |
|
Jinyu Bio-Technology Co.
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 18
|
$2.7B |
N/A |
N/A |
|
BioKangtai
|
China |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
CNY 16
|
$2.5B |
6.1x |
22.8x |
|
Immunome
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$2.4B |
314.6x |
-11.6x |
|
SK Bioscience
|
South Korea |
Vaccines & Immunotherapies
|
KRW 50700
|
$2.3B |
5.2x |
-83.2x |
|
AstraZeneca India
|
India |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
INR 8608
|
$2.3B |
N/A |
N/A |
|
Bavarian Nordic
|
Denmark |
Vaccines & Immunotherapies
|
DKK 192
|
$1.9B |
2.0x |
5.6x |
|
Arcus Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
$21
|
$1.9B |
7.6x |
-5.2x |
|
Corvus Pharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$21
|
$1.7B |
N/A |
N/A |
|
Everest Medicines
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
HKD 39
|
$1.6B |
6.5x |
280.7x |
|
Hualan Biological Vaccine
|
China |
Vaccines & Immunotherapies
|
CNY 22
|
$1.6B |
N/A |
N/A |
|
GC Biopharma
|
South Korea |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
KRW 15669
|
$1.5B |
N/A |
N/A |
|
Dynavax
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$15
|
$1.4B |
4.1x |
57.0x |
|
Upstream Bio
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$31
|
$1.3B |
491.1x |
-8.5x |
|
Chengdu Kanghua
|
China |
Vaccines & Immunotherapies
|
CNY 72
|
$1.2B |
6.6x |
18.0x |
|
Changchun BCHT
|
China |
Vaccines & Immunotherapies
|
CNY 20
|
$1.2B |
N/A |
N/A |
|
Immunocore Holdings
|
Germany |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€27
|
$1.2B |
N/A |
N/A |
|
AnaptysBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$47
|
$1.1B |
5.3x |
-39.9x |
|
Allergy Therapuetics
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£0
|
$1.1B |
12.6x |
-31.8x |
|
Celldex Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$1.1B |
405.0x |
-4.1x |
|
HBM Holdings
|
Hong Kong |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
HKD 12
|
$1.0B |
N/A |
N/A |
|
CStone Pharmaceuticals
|
Hong Kong |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
HKD 5
|
$969M |
31.5x |
-26.1x |
|
Keqian Biology
|
China |
Vaccines & Immunotherapies
|
CNY 17
|
$934M |
5.9x |
12.5x |
|
Compass Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$927M |
N/A |
-12.0x |
|
Novavax
|
United States of America |
Vaccines & Immunotherapies
|
$9
|
$926M |
0.9x |
2.4x |
|
Valneva
|
France |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
€4
|
$859M |
4.3x |
-16.6x |
|
Liaoning Chengda Biotech
|
China |
Vaccines & Immunotherapies
|
CNY 26
|
$836M |
N/A |
N/A |
|
CytomX Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$828M |
10.0x |
-76.2x |
|
Immatics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$784M |
16.7x |
-4.0x |
|
AIM Vaccine
|
Hong Kong |
Vaccines & Immunotherapies
|
HKD 3
|
$727M |
3.9x |
N/A |
|
Vir Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$7
|
$630M |
30.3x |
-1.3x |
|
Nektar Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$37
|
$581M |
13.5x |
-3.9x |
|
Shanghai Hile Bio-Tech
|
China |
Vaccines & Immunotherapies
|
CNY 6
|
$542M |
N/A |
N/A |
|
Luzhu Biotech
|
Hong Kong |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
HKD 22
|
$536M |
N/A |
N/A |
|
Renata
|
Bangladesh |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
BDT 432
|
$535M |
N/A |
N/A |
|
Northwest Biotherapeutics
|
United States of America |
Vaccines & Immunotherapies
|
$0
|
$521M |
N/A |
N/A |
|
Recbio
|
Hong Kong |
Vaccines & Immunotherapies
|
HKD 5
|
$508M |
N/A |
N/A |
|
Ocugen
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Genomics & Personalized Medicine
|
$1
|
$475M |
84.8x |
N/A |
|
GlaxoSmithKline Pakistan
|
Pakistan |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
PKR 420
|
$456M |
N/A |
N/A |
|
Kamada
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
ILS 26
|
$419M |
2.3x |
9.4x |
|
Greenwich LifeSciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$30
|
$413M |
N/A |
N/A |
|
Invivyd
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$408M |
8.1x |
-7.3x |
|
Medigen Vaccine Biologics
|
Taiwan |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
TWD 38
|
$347M |
N/A |
N/A |
|
Kyverna Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$8
|
$311M |
N/A |
-1.8x |
|
Transgene
|
France |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€1
|
$308M |
28.1x |
-7.8x |
|
Ourofino
|
Brazil |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
BRL 25
|
$307M |
N/A |
N/A |
|
Replimune Group
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$7
|
$303M |
241.1x |
-1.0x |
|
Adimmune
|
Taiwan |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
TWD 19
|
$300M |
N/A |
N/A |
|
Immix Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$294M |
N/A |
-11.4x |
|
Faron Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£2
|
$276M |
N/A |
-9.9x |
|
Candel Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$240M |
N/A |
-5.2x |
|
Allogene Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$238M |
131143.9x |
-1.2x |
|
Lyell Immunopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$24
|
$235M |
10422.9x |
-1.3x |
|
Enlivex Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$223M |
N/A |
N/A |
|
Scancell
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£0
|
$198M |
68.8x |
-10.3x |
|
AC Immune
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$185M |
5.6x |
N/A |
|
Shattuck Labs
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$162M |
135.0x |
-3.4x |
|
Vaxcell-Bio
|
South Korea |
Vaccines & Immunotherapies
|
KRW 10450
|
$151M |
N/A |
N/A |
|
Agenus
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$145M |
1.1x |
N/A |
|
Turk İlaç
|
Turkey |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
TRY 19
|
$132M |
N/A |
N/A |
|
Elicio Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$8
|
$127M |
N/A |
N/A |
|
OSE Immunotherapeutics
|
France |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€5
|
$123M |
2.4x |
-41.4x |
|
CHO Pharma
|
Taiwan |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
TWD 28
|
$119M |
N/A |
N/A |
|
Cabaletta Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$113M |
N/A |
-0.6x |
|
Coherus Oncology
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$110M |
2.5x |
-0.6x |
|
Acepodia
|
Taiwan |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
TWD 14
|
$106M |
N/A |
N/A |
|
SAB Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$103M |
N/A |
N/A |
|
Celularity
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine,
Vaccines & Immunotherapies
|
$1
|
$102M |
N/A |
N/A |
|
Genelux
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$101M |
N/A |
N/A |
|
Oncolytics Biotech
|
United States of America |
Vaccines & Immunotherapies
|
$1
|
$97.6M |
N/A |
-3.9x |
|
Compugen
|
Israel |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
ILS 6
|
$95.4M |
13.1x |
N/A |
|
Anixa Biosciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$86.5M |
N/A |
N/A |
|
Eledon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$82.5M |
N/A |
N/A |
|
Tevogen Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$0
|
$75.8M |
N/A |
N/A |
|
Adagene
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$74.1M |
14.8x |
N/A |
|
Inovio Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$70.5M |
798.3x |
N/A |
|
Coya Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$69.6M |
11.8x |
N/A |
|
Autolus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
$1
|
$63.0M |
0.8x |
-0.2x |
|
Imugene
|
Australia |
Vaccines & Immunotherapies
|
AUD 0
|
$54.6M |
16.8x |
-1.5x |
|
Instil Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$7
|
$53.1M |
N/A |
N/A |
|
MiNK Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$12
|
$46.7M |
N/A |
N/A |
|
Nykode Therapeutics
|
Norway |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
NOK 3
|
$46.4M |
45.0x |
-1.6x |
|
Cartesian Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$7
|
$46.0M |
23.4x |
N/A |
|
Prescient Therapeutics
|
Australia |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
AUD 0
|
$45.0M |
N/A |
N/A |